Lauri Ivaska

874 citations
25 papers · 259 · h-index 11

Impact in

  • Microbiology top 10%
    • Bacterial Infections and Vaccines
    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • Viral gastroenteritis research and epidemiology

Papers in

    • Respiratory viral infections research 8
    • Infective Endocarditis Diagnosis and Management 5
    • Influenza Virus Research Studies 4
    • Pneumonia and Respiratory Infections 4
    • SARS-CoV-2 and COVID-19 Research 6
    • SARS-CoV-2 detection and testing 3

Lauri Ivaska

23 papers receiving 248 citations

Peers

Lauri Ivaska
Comparison fields: 5 of 58
  • Microbiology 63
  • Infectious Diseases 118
  • Epidemiology 139
  • Applied Microbiology and Biotechnology 8
  • Public Health, Environmental and Occupational Health 48
Replace Gülnar Şensoy with:
Gülnar Şensoy Türkiye
Thomas Waterfield United Kingdom
Natalie G. Martin New Zealand
Soha Ghanem Lebanon
Vittorio Attanasio Italy
Entesar H. Husain Kuwait
Martina Cortimiglia Italy
Juan Carlos Alados Spain
Michael D. Nowak United States
Osamu Komiyama Japan
Lauri Ivaska relative to Gülnar Şensoy Türkiye Gülnar Şensoy's profile →
Citations per field
00.5×
Gülnar Şensoy · 1×
Citations per year

Countries citing papers authored by Lauri Ivaska

Since Specialization
Citations

This map shows the geographic impact of Lauri Ivaska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauri Ivaska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauri Ivaska more than expected).

Fields of papers citing papers by Lauri Ivaska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauri Ivaska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauri Ivaska. The network helps show where Lauri Ivaska may publish in the future.

Co-authors

The 25 scholars most cited alongside Lauri Ivaska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lauri Ivaska Line = papers co-authored together Lauri Ivaska links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202235
2 202233
3 201530
4 201724
5 201322
6 202315
7 202213
8 202310
9 201610
10 202210
11 201510
12 202210
13 20249
14 20208
15 20245
16 20224
17 20233
18 20232
19 20222
20 20241

About Lauri Ivaska

Lauri Ivaska is a scholar working on Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Microbiology and Surgery, having authored 25 papers that have together received 259 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (8 papers), Respiratory viral infections research (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Infective Endocarditis Diagnosis and Management (5 papers), Bacterial Infections and Vaccines (5 papers), Influenza Virus Research Studies (4 papers), Pneumonia and Respiratory Infections (4 papers) and SARS-CoV-2 detection and testing (3 papers). The work is most often cited by research in Microbiology (63 citations), Infectious Diseases (118 citations), Epidemiology (139 citations), Applied Microbiology and Biotechnology (8 citations) and Public Health, Environmental and Occupational Health (48 citations). Lauri Ivaska has collaborated with scholars based in Finland, Canada and Singapore. Frequent co-authors include Ville Peltola, Jussi Mertsola, Jussi Niemelä, Alex‐Mikael Barkoff, Tytti Vuorinen, Qiushui He, Matti Waris, Johanna Lempainen, Riikka Österback and Paula A. Tähtinen. Their work appears in journals such as Journal of Infection, Frontiers in Immunology, Open Forum Infectious Diseases, The Journal of Infectious Diseases and Microbiology Spectrum.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact